REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

CSOTO PHARMA Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: CSOTO PHARMA Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

CSOTO PHARMA Kft. is an enterprise based in Hungary. Its main office is in Boly. The company operates in the Pharmacies and Drug Stores sector. The company was established on January 01, 2021. 6 (2024) employees currently work for CSOTO PHARMA Kft.. In its most recent financial highlights, the company reported a net sales revenue increase of 10.22% in 2023. Over the same period, its total assets grew by 7.95%. In 2023, CSOTO PHARMA Kft.’s net profit margin decreased by 1.72%.

Headquarters
Ady Endre utca 8.
Boly; Baranya; Postal Code: 7754

Contact Details: Purchase the CSOTO PHARMA Kft. report to view the information.

Basic Information
Total Employees:
Purchase the CSOTO PHARMA Kft. report to view the information.
Outstanding Shares:
Purchase the CSOTO PHARMA Kft. report to view the information.
Registered Capital:
Purchase the CSOTO PHARMA Kft. report to view the information.
Incorporation Date:
January 01, 2021
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after CSOTO PHARMA Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
10.22%▲
Total operating revenue
11.06%▲
Operating profit (EBIT)
-42.69%▼
EBITDA
-40.72%▼
Net Profit (Loss) for the Period
-42.82%▼
Total assets
7.95%▲
Total equity
13.57%▲
Operating Profit Margin (ROS)
-1.89%▼
Net Profit Margin
-1.72%▼
Return on Equity (ROE)
-11.78%▼
Quick Ratio
0.69%▲
Cash Ratio
0.75%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo